MS Treatment Options: Medications, Therapies & Emerging Approaches

Medically Reviewed by Dr. José A. Jiménez, Medical Director — Medical Doctor and Surgeon (UNAM), Specialist in Critical Care and Intensive Care Medicine, with advanced training in Stem Cell Therapy, Sports Medicine, and Musculoskeletal Ultrasound. More than 30 years of medical experience. Last Reviewed: August 2026

Treatment for multiple sclerosis generally falls into three categories: disease-modifying therapies (DMTs) that reduce relapse frequency and slow new nerve damage, medications that manage individual symptoms, and rehabilitative therapies such as physical therapy. Some patients also research regenerative approaches, including stem cell therapy, as a complementary option. This guide walks through each category.

There’s no single “best” MS treatment plan — the right combination depends on your MS type, disease activity, symptoms, and personal priorities, and it typically evolves over the course of the disease as circumstances change. What follows is meant to give you a clear, working understanding of the options so you can have a more informed conversation with your neurologist, not to replace that conversation.

Get in Touch

Send us a message and our team will get back to you shortly.

Disease-Modifying Therapies (DMTs)

DMTs are the backbone of standard MS treatment today. Over a dozen DMTs are now approved for MS, compared to only a handful available before 2010 — a shift researchers describe as one of the most significant advances in the field over the past three decades. These medications work by modulating or suppressing immune activity to reduce the frequency and severity of relapses. Newer oral and infusion therapies have generally shown better control of disease activity than older injectable options, though they come with their own safety-monitoring requirements that your neurologist will walk you through.

Importantly, DMTs manage inflammation and reduce relapses — they do not reverse existing nerve damage, and they’re generally less effective for progressive forms of MS than for relapsing-remitting MS.

Choosing among DMTs typically involves weighing effectiveness against convenience and side-effect profile. Some are taken as daily pills, others as periodic injections, and others as infusions given every few months to once a year at a clinic. Newer, higher-efficacy options tend to come with more involved monitoring requirements — regular bloodwork or MRI surveillance, for instance — which is part of why this decision is usually made collaboratively with a neurologist familiar with your full medical history, rather than from a general list of options alone.

Get in Touch

Send us a message and our team will get back to you shortly.

Managing Individual Symptoms

Beyond DMTs, many patients use additional medications and strategies to manage specific symptoms such as spasticity, fatigue, bladder dysfunction, or nerve pain. These are typically prescribed alongside — not instead of — a DMT, and are adjusted over time as symptoms change.

During an active relapse, short courses of corticosteroids are commonly used to reduce inflammation and shorten the duration of the flare, though they don’t change the disease’s long-term course and can carry side effects like mood changes, sleep disruption, or elevated blood sugar with repeated use. For symptom management day to day, options range from medications targeting specific issues like spasticity or bladder urgency, to non-drug strategies like cooling vests for heat sensitivity or scheduled rest periods to manage fatigue.

Physical Therapy & Rehabilitation

Physical therapy can help improve balance, coordination, and muscle strength, which can reduce fall risk and support day-to-day mobility. It’s most effective as an ongoing part of MS management rather than a one-time intervention, and many patients combine it with occupational therapy for daily-living skills.

A physical therapist familiar with MS will typically build a program around your specific limitations — some patients focus more on gait and balance training, others on strength and flexibility, and others on energy conservation techniques for managing fatigue. Because MS symptoms can change over time, rehabilitation plans are usually revisited periodically rather than set once and left unchanged.

Emerging & Regenerative Approaches

Because current DMTs manage inflammation but don’t reverse existing damage, researchers continue to explore regenerative approaches, including mesenchymal stem cell (MSC) therapy, which is being studied for its potential immunomodulatory effects. Renovo Health and Beauty in Tijuana offers stem cell therapy for MS patients interested in exploring this option as a complement to their existing care — our stem cell therapy for MS page covers what current research shows in more depth.

If you’re trying to determine whether this or any other emerging approach is worth discussing with your care team, our guide on who is a good candidate for stem cell therapy is a useful starting point, as is our overview of stem cell therapy for neurological conditions more broadly.

Microscopic view of neural or cellular structures with glowing pink and blue elements.

How Treatment Decisions Are Typically Made

Neurologists generally weigh a few key factors when recommending a treatment approach: how active the disease currently is (based on relapse frequency and MRI findings), which MS subtype you have, your age and overall health, and your own priorities around side effects, monitoring requirements, and lifestyle. Treatment plans are rarely static — many patients switch or adjust DMTs at some point, whether due to changing disease activity, side effects, or new treatment options becoming available. This is one of the reasons an ongoing relationship with a neurologist matters more in MS than a single treatment decision made at diagnosis.

Lifestyle Factors That Support Any Treatment Plan

Whatever treatment path a patient follows, certain lifestyle factors tend to support better outcomes alongside it. Regular exercise, adequate sleep, and stress management are consistently associated with better day-to-day symptom control, and managing cardiovascular risk factors like blood pressure and cholesterol has been linked to slower long-term disability progression in research on MS populations. None of these replace DMTs or medical treatment, but they’re increasingly treated as a meaningful complement rather than an afterthought in comprehensive MS care.

Talking to Your Neurologist About Your Options

If any part of this guide raises questions specific to your own case — whether about switching DMTs, adding a symptom-management medication, or exploring an emerging approach — the most productive next step is usually a direct, specific conversation with your neurologist rather than researching in isolation. Bringing a written list of questions to your next appointment, including anything you’ve read about regenerative approaches like stem cell therapy, tends to make that conversation more productive than trying to cover everything from memory.

Frequently Asked Questions

Most patients with relapsing-remitting MS start on a disease-modifying therapy shortly after diagnosis, since earlier treatment is generally associated with better long-term outcomes.

DMT options for progressive MS are more limited than for relapsing-remitting MS, and effectiveness varies. Your neurologist can advise on options specific to your MS type.

Stem cell therapy for MS remains an area of active research rather than a standard first-line treatment. Patients interested in it should discuss it as a complementary option alongside their existing care.

No — physical therapy supports mobility and function but does not modify the underlying disease process the way DMTs do. Most patients benefit from both.

It varies by patient, but many people adjust or switch treatments at some point due to changes in disease activity, side effects, or the availability of newer options.

No. Corticosteroids are generally used for short courses during an active relapse to reduce inflammation, not as an ongoing disease-modifying treatment.